Description
Humanin HNG (S14G-humanin)
Humanin is a protective peptide produced in the mitochondria that has been studied for its potential involvement in promoting cellular longevity, supporting brain health, improving metabolic function, and contributing to anti-aging processes. Initially identified during research on Alzheimer’s disease, HN is recognized for its ability to shield cells from oxidative stress, mitochondrial impairment, and programmed cell death. It has since drawn considerable interest in the fields of longevity science and biohacking due to its possible positive effects on cognitive performance, insulin responsiveness, heart health, and mechanisms linked to healthy aging.
Also known as: HN
• Status: Preclinical phase with substantial animal research conducted. Evidence based on animal studies.
• Standard dosage: 5–10 mg per week, split into 2–3 injections (administered two to three times weekly, such as on Monday, Wednesday, and Friday). Route of administration may vary.
• Investigated for potential benefits in neuroprotection, metabolic function, and cellular aging.
• Standard dosage: 5–10 mg per week, split into 2–3 injections (administered two to three times weekly, such as on Monday, Wednesday, and Friday). Route of administration may vary.
• Investigated for potential benefits in neuroprotection, metabolic function, and cellular aging.
Reviews
There are no reviews yet.